Neuropilin-1 attenuates autoreactivity in experimental autoimmune encephalomyelitis.
Neuropilin-1 (Nrp1) is a cell surface molecule originally identified for its role in neuronal development. Recently, Nrp1 has been implicated in several aspects of immune function including maintenance of the immune synapse and development of regulatory T (T(reg)) cells. In this study, we provide evidence for a central role of Nrp1 in the regulation of CD4 T-cell immune responses in experimental autoimmune encephalitis (EAE). EAE serves as an animal model for the central nervous system (CNS) inflammatory disorder multiple sclerosis (MS). EAE is mediated primarily by CD4(+) T cells that migrate to the CNS and mount an inflammatory attack against myelin components, resulting in CNS pathology. Using a tissue-specific deletion system, we observed that the lack of Nrp1 on CD4(+) T cells results in increased EAE severity. These conditional knockout mice exhibit preferential T(H)-17 lineage commitment and decreased T(reg)-cell functionality. Conversely, CD4(+) T cells expressing Nrp1 suppress effector T-cell proliferation and cytokine production both in vivo and in vitro independent of T(reg) cells. Nrp1-mediated suppression can be inhibited by TGF-β blockade but not by IL-10 blockade. These results suggest that Nrp1 is essential for proper maintenance of peripheral tolerance and its absence can result in unchecked autoreactive responses, leading to diseases like EAE and potentially MS.
Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.
Benjamin D
BD
Solomon
Cynthia
C
Mueller
Wook-Jin
WJ
Chae
Leah M
LM
Alabanza
Margaret S
MS
Bynoe
D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000276:immunology*; D007111:Immunity, Cellular; D053645:Interleukin-2 Receptor alpha Subunit / Q000276:immunology; D051379:Mice; D018345:Mice, Knockout; D008822:Mice, Transgenic; D039942:Neuropilin-1 / Q000235:genetics / Q000502:physiology*
D053645:Interleukin-2 Receptor alpha Subunit; D039942:Neuropilin-1
Nat Rev Immunol. 2003 Feb;3(2):159-67
12563299
Ann Neurol. 2007 Jun;61(6):504-13
17492755
Cell. 1998 Sep 4;94(5):667-77
9741631
Trends Cell Biol. 1996 Jan;6(1):15-22
15157527
Expert Rev Neurother. 2007 Sep;7(9):1175-88
17868016
Nat Immunol. 2007 Dec;8(12):1390-7
17994024
J Comp Neurol. 2007 May 10;502(2):236-60
17348011
Dev Comp Immunol. 2007;31(11):1082-94
17374393
Immunity. 2003 Sep;19(3):317-28
14499108
Immunity. 2008 Mar;28(3):402-13
18328743
J Immunol. 2004 Dec 1;173(11):6526-31
15557141
Immunity. 2006 May;24(5):591-600
16713976
J Exp Med. 1973 May 1;137(5):1142-62
4573839
Adv Exp Med Biol. 2002;515:1-12
12613539
Cell. 1997 Aug 22;90(4):753-62
9288754
Nat Rev Immunol. 2004 Nov;4(11):841-55
15516964
Cell. 1999 Oct 1;99(1):59-69
10520994
Am J Transplant. 2004 Oct;4(10):1614-27
15367216
J Leukoc Biol. 2008 Jul;84(1):302-10
18436584
Eur J Immunol. 2004 Mar;34(3):623-630
14991591
Biochem Biophys Res Commun. 2009 Aug 14;386(1):105-10
19501566
Dev Cell. 2003 Jul;5(1):45-57
12852851
Annu Rev Med. 2002;53:285-302
11818475
J Exp Med. 2008 Sep 1;205(9):1983-91
18725525
J Exp Med. 2003 May 5;197(9):1073-81
12732654
Int Immunol. 2008 Mar;20(3):413-20
18209113
Proc Natl Acad Sci U S A. 1995 Jan 17;92(2):354-8
7530361
Nat Immunol. 2006 Nov;7(11):1151-6
16998492
Nat Immunol. 2002 May;3(5):477-82
11953749